Introduction
Tasmania is on the brink of a healthcare revolution that will fundamentally change how residents access medical treatment for common conditions. The role of pharmacists in community health is expanding dramatically, with the Tasmanian Government announcing a groundbreaking $5 million investment to enable pharmacists to treat more than 20 health conditions by 2026.
This transformative initiative brings Tasmania in line with Queensland and the Northern Territory, where extended scope pharmacy practice has already proven successful in improving healthcare access and reducing pressure on the medical system. For Tasmanian residents, particularly those in regional areas where GP appointments can involve weeks of waiting, this expansion represents a significant improvement in healthcare accessibility.
The journey towards extended pharmacy services in Tasmania began with the independent Pharmacist Scope of Practice Review, which provided evidence-based recommendations for expanding the role of community pharmacists. With legislative changes already implemented in June 2025, Tasmania is now positioned to offer its residents the same convenient, accessible healthcare services that have benefited patients in other Australian states.
Key Summary
- Tasmania will enable pharmacists to treat more than 20 health conditions by 2026, matching Queensland’s comprehensive model
- $5 million investment announced for pharmacist training and service expansion, including subsidies for professional development
- UTI treatment and contraceptive pill services already successfully implemented, freeing up thousands of GP appointments
- New services include ear infections, reflux, skin conditions, rhinitis, and wound care – conditions representing high-volume preventable hospital presentations
- Nation-leading aged care pharmacy pilot to commence, allowing pharmacists to co-prescribe medications in residential facilities
- Training subsidies available for pharmacists to upskill, ensuring rapid adoption across the state
- Expected to free up thousands of GP appointments annually, allowing doctors to focus on complex cases
Current Pharmacy Services in Tasmania
Tasmania’s journey towards extended pharmacy practice began with careful, evidence-based implementation of targeted services. The most significant milestone was the commencement of the UTI treatment program on 1 March 2024, which marked the first time Tasmanian pharmacists could prescribe antibiotics for uncomplicated urinary tract infections.
This pioneering program has been a resounding success. Eligible pharmacists, working in approved premises, can now assess and treat women aged 18-65 presenting with uncomplicated UTIs, prescribing appropriate antibiotics without the need for a GP visit. The program, which concluded its pilot phase on 28 February 2025, is currently being evaluated with a final report expected later in 2025. However, pharmacists who completed the required training can continue providing UTI services in accordance with the authorised protocol.
Building on this success, Tasmania expanded pharmacy services to include the extension of oral contraceptive pill prescriptions. Endorsed pharmacists can now extend the supply of oral contraceptive pills for up to 12 months for eligible patients, a service that has significantly improved access to essential reproductive healthcare across the state.
The legislative framework supporting these changes came into effect on 4 June 2025, with community pharmacists acting in accordance with authorised protocols now considered authorised health professionals under Regulation 7 of the Tasmanian Poisons Regulations 2018. This legal recognition ensures that pharmacists can prescribe prescription medicines without needing individual endorsement, provided they meet mandatory requirements including holding general registration with the Pharmacy Board of Australia and maintaining proper consultation and prescribing records.
Additionally, Tasmania has significantly expanded its vaccination program. Authorised Pharmacist Immunisers (APIs) can now independently administer an expanded scope of vaccines, including all National Immunisation Program vaccines, subject to completing required training. From 1 January 2025, all APIs must have completed additional training modules to maintain their authorisation, ensuring the highest standards of care.
The impact of these current services has been substantial. With Australia’s pharmacy workforce stepping up to meet demand, approximately 7,000 Tasmanian appointments have been redirected from GPs and emergency departments to community pharmacies over the past few years. This has not only improved patient access to timely care but has also allowed medical practitioners to focus on more complex cases requiring their specialised expertise.
The 20+ Conditions Coming in 2026
The 2025-26 Budget allocation of $5 million represents a watershed moment for Tasmanian healthcare, enabling pharmacists to undergo subsidised training to treat a comprehensive range of conditions. This expansion follows the successful Queensland model, where pharmacists already provide treatment for more than 20 everyday and long-term health conditions.
The conditions specifically mentioned in the government announcement include ear infections, gastroesophageal reflux disease (GERD), skin conditions such as shingles and eczema, rhinitis, and wound care. However, based on the Queensland model that Tasmania is adopting, the full list is expected to include:
- Acute otitis media (middle ear infections)
- Gastroesophageal reflux disease (GERD)
- Shingles (herpes zoster)
- Eczema and dermatitis (atopic, allergic, and contact)
- Allergic rhinitis
- Wound management and care
- Impetigo (school sores)
- Mild to moderate acne
- Conjunctivitis (bacterial and allergic)
- Oral thrush (candidal stomatitis)
- Cold sores (herpes labialis)
- Haemorrhoids
- Insect bites and urticaria
- Musculoskeletal sprains and strains
- Nausea and vomiting (including pregnancy-related)
- Dysmenorrhoea (period pain)
- Minor burns and scalds
- Fungal nail infections
- Psoriasis (mild to moderate)
- Head lice
- Threadworms and pinworms
These conditions were carefully selected based on several criteria. They represent the highest volume of preventable hospital presentations and PBS prescribing, are generally self-limiting or manageable with minimal treatment, and have well-established treatment protocols. The evolving role of pharmacists in treating these conditions requires comprehensive training beyond traditional pharmacy education.
The training requirements for pharmacists are substantial and rigorous. To deliver these expanded services, pharmacists must complete accredited postgraduate training programs covering clinical assessment, diagnosis, and treatment protocols for each condition. The government’s subsidy program will provide financial support to pharmacists undertaking this training, similar to Queensland where training subsidies led to early adoption with over 100 prescribing pharmacists already practicing.
The implementation timeline is carefully structured to ensure quality and safety. Following the budget announcement in May 2025, training programs are being developed in consultation with universities and the Pharmaceutical Society of Australia. Pharmacists are expected to begin enrolling in training programs by late 2025, with the first cohort of trained pharmacists ready to deliver expanded services by early to mid-2026.
Tasmania’s approach also includes a nation-leading innovation: a pilot program enabling pharmacists to co-prescribe medications in aged care facilities in collaboration with GPs. This Australian-first initiative will develop a study to assess outcomes when pharmacists can co-prescribe medications for residents according to treatment plans, with the model being trialled for 12 months through 2026 and 2027.
What This Means for Tasmanian Patients
The expansion of pharmacy services represents a fundamental shift in how Tasmanians access healthcare, particularly benefiting those in regional and remote areas where GP availability is limited. With community pharmacies located within 2.5-5km of where most Australians live, these services bring healthcare closer to home for thousands of Tasmanians.
For patients, the most immediate benefit is dramatically improved access to timely healthcare. Instead of waiting weeks for a GP appointment for common conditions like ear infections or eczema, patients can often see a pharmacist the same day. This is particularly valuable for parents with sick children, workers who struggle to take time off for medical appointments, and elderly residents who may find travelling to medical centres challenging.
The cost implications are generally favourable for patients. While specific pricing structures are still being finalised, the Queensland model shows that pharmacy consultations are often more affordable than GP visits, especially when considering indirect costs like time off work and travel. Medicare rebates may apply to some services, and the convenience factor alone provides significant value. Patients should expect to pay for medications prescribed, similar to current arrangements, with PBS subsidies applying where eligible.
Accessing these new services will be straightforward. Patients can visit participating pharmacies without needing a referral or appointment in many cases, though some pharmacies may offer appointment booking for convenience. Professional pharmacists with specialised training will conduct consultations in private consulting rooms, ensuring confidentiality and professional standards matching those of general practice.
During a pharmacy consultation for these expanded services, patients can expect a thorough, professional experience. The pharmacist will:
- Take a detailed medical history and ask about current symptoms
- Conduct appropriate physical examinations where necessary (such as examining ears for ear infections or assessing skin conditions)
- Review current medications to check for interactions
- Discuss treatment options and provide clear explanations
- Prescribe appropriate medications when indicated
- Provide written information about the condition and treatment
- Advise when to seek further medical attention if symptoms don’t improve
- Communicate with the patient’s regular GP about the consultation and treatment provided
The service maintains high safety standards through clear protocols and referral pathways. Pharmacists are trained to recognise “red flags” that require immediate medical attention and will refer patients to GPs or emergency departments when conditions fall outside their scope of practice. This includes patients under 18 or over 65 for certain conditions, pregnant women for specific treatments, and anyone presenting with symptoms suggesting a more serious underlying condition.
For regional Tasmania, where some areas experience GP shortages and lengthy wait times, these services are particularly transformative. Rural residents who previously might have delayed seeking treatment due to distance or availability can now access care locally, potentially preventing complications from untreated conditions.
Conclusion
Tasmania’s expansion of pharmacy services marks a pivotal moment in the state’s healthcare evolution. By 2026, Tasmanians will have access to treatment for more than 20 common health conditions at their local pharmacy, bringing the state in line with leading jurisdictions and significantly improving healthcare accessibility.
This transformation goes beyond mere convenience. It represents a fundamental reimagining of primary healthcare delivery, recognising pharmacists as essential healthcare providers capable of managing a broad range of conditions safely and effectively. The $5 million investment in training and infrastructure demonstrates the government’s commitment to ensuring these services are delivered to the highest professional standards.
The success of the UTI treatment program and contraceptive pill services has already proven that Tasmanian pharmacists are ready and capable of taking on these expanded responsibilities. With thousands of appointments already redirected from overwhelmed GP clinics and emergency departments, the full implementation of expanded services promises even greater benefits for the healthcare system and patients alike.
Looking ahead, the nation-leading aged care pharmacy pilot positions Tasmania at the forefront of innovative healthcare delivery models. As pharmacy practice continues to evolve, Tasmania is demonstrating how strategic investment in pharmacist training and scope expansion can create a more accessible, efficient, and patient-centred healthcare system.
For Tasmanian residents, the message is clear: your local pharmacist is becoming an increasingly valuable first point of contact for healthcare needs. As these services roll out through 2026, we encourage all Tasmanians to familiarise themselves with what’s available and take advantage of these convenient, professional healthcare services in their community. The future of healthcare in Tasmania is closer than ever – it’s right at your local pharmacy.
FAQs
- • Who can access these expanded pharmacy services?
The expanded pharmacy services will be available to all Tasmanian residents, though specific age restrictions may apply for certain conditions. For example, UTI treatment is currently available for women aged 18-65, while vaccination services have different age criteria. Children and elderly patients can access many services, but some conditions may require GP referral based on age or complexity. Each participating pharmacy will clearly display which services they offer and any eligibility criteria. - • Do I need a referral to see a pharmacist for treatment?
No, you don’t need a referral to access pharmacy treatment services. One of the key benefits of expanded pharmacy services is direct access – you can walk into a participating pharmacy or book an appointment directly. However, pharmacists will communicate with your regular GP about any treatment provided to ensure continuity of care. If you don’t have a regular GP, the pharmacist can provide you with information to help you find one for ongoing healthcare needs. - • Will these services cost more than seeing a GP?
Generally, pharmacy consultations are expected to be competitively priced and may be more affordable than GP visits, especially when considering indirect costs like time off work. While specific pricing is still being finalised, the Queensland experience shows pharmacy services often cost less than standard GP consultations. Some services may attract Medicare rebates, and prescribed medications will be eligible for PBS subsidies where applicable. Individual pharmacies will provide clear pricing information before consultations. - • How do I know if my condition can be treated by a pharmacist?
Participating pharmacies will display information about which conditions they can treat, and pharmacists are trained to assess whether your condition falls within their scope of practice. Common conditions like ear infections, UTIs, skin conditions, and minor wounds will generally be treatable. If you’re unsure, you can phone or visit your local pharmacy to ask. Pharmacists will always refer you to a GP or emergency department if your condition requires medical attention beyond their scope. - • What training do pharmacists undergo for these services?
Pharmacists must complete comprehensive accredited postgraduate training programs before delivering expanded services. This includes modules on clinical assessment, diagnosis, treatment protocols, and when to refer patients for medical care. For example, UTI treatment requires completion of specific training through the Pharmaceutical Society of Australia or Australasian College of Pharmacy. The government is subsidising this training to ensure rapid uptake, with programs developed in consultation with universities to maintain the highest professional standards.
Information Sources
- Tasmanian Department of Health – Tasmanian Community Pharmacy Program
- Tasmanian Department of Health – Pharmacist Immunisation Program Guidelines
- Premier of Tasmania – Official Media Releases on Pharmacy Expansion
- Pharmacy Guild of Australia – Tasmania Branch
- Pharmaceutical Society of Australia – UTI Resources Tasmania
- Australian Government Department of Health – Pharmacy Programs
- Retail Pharmacy Magazine – Tasmania Pharmacy Updates
- Australian Health Practitioner Regulation Agency (AHPRA)
- Tasmanian Pharmacy Authority
- Australian Pharmacy Council – Accreditation Standards
